POINT Biopharma Global Inc. Common Stock

PNT

Market cap $1.33B

Delisted

PNT was delisted on the 26th of December, 2023.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	1 BlackRock New York	$21.6M	+$20.5M	+1,500,000	New
2	BC 2 Boxer Capital San Diego, California	$21.6M	+$20.5M	+1,500,000	New
3	PA 3 Perceptive Advisors New York	$21.6M	+$20.5M	+1,500,000	New
4	ACA 4 Avoro Capital Advisors New York	$14.4M	+$13.6M	+1,000,000	New
5	BCLSI 5 Bain Capital Life Sciences Investors Boston, Massachusetts	$14.4M	+$13.6M	+1,000,000	New
6	BI 6 BVF Inc San Francisco, California	$14.4M	+$13.6M	+1,000,000	New
7	7 Franklin Resources San Mateo, California	$14.4M	+$13.6M	+1,000,000	New
8	8 T. Rowe Price Associates Baltimore, Maryland	$13.3M	+$12.6M	+921,822	New
9	9 Wellington Management Group Boston, Massachusetts	$13.1M	+$12.4M	+908,671	New
10	10 Citadel Advisors Miami, Florida	$7.2M	+$6.83M	+500,814	New
11	CAM 11 Cormorant Asset Management Boston, Massachusetts	$7.19M	+$6.82M	+500,000	New
12	LGM 12 Logos Global Management San Francisco, California	$7.19M	+$6.82M	+500,000	New
13	RI 13 RTW Investments New York	$7.05M	+$6.68M	+490,000	New
14	FCMI 14 Foresite Capital Management IV Larkspur, California	$5.03M	+$4.77M	+350,000	New
15	15 Janus Henderson Group London,	$1.79M	+$1.7M	+124,666	New
16	16 TD Asset Management Toronto, Ontario, Canada	$708K	+$672K	+49,262	New
17	MIM 17 Monashee Investment Management Boston, Massachusetts	$680K	+$645K	+47,271	New
18	SFM 18 Sphera Funds Management Tel Aviv, Israel	$288K	+$273K	+20,000	New